No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype

British Journal of Cancer

Volumn 93, Issue 1, 2005, Pages 167-171

  Bojesen, S E ^a   Tybjaerg Hansen A ^b,c   Axelsson, C K ^a   Nordestgaard, B G ^a,b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Breast cancer; Case control; Genetic epidemiology; Genetic polymorphism; Integrins

Indexed keywords

BETA3 INTEGRIN; LEUCINE; PROLINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTEGRIN BETA3; LEUCINE; MIDDLE AGED; PROLINE;

EID: 23044481934     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602674     Document Type: Article

References (18)

1. Appleyard M, Tybjærg-Hansen A, Jensen G, Schnohr P, Nyboe J (1989) The Copenhagen City Heart Study. Østerbroundersøgelsen. A book of tables with data from the first examination (1976-78) and a five year follow-up (1981-1983). Scand J Soc Med 170(Suppl 41): 1-160
2. Ayala F, Corral J, Gonzalez-Conejero R, Sanchez I, Moraleda JM, Vicente V (2003) Genetic polymorphisms of platelet adhesive molecules: association with breast cancer risk and clinical presentation. Breast Cancer Res Treat 80: 145-154, Pubmed# indexed for MEDLINE: PM:12908817
3. Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer. Br J Cancer 11: 359-377
4. Bojesen SE, Tybjærg-Hansen A, Nordestgaard BG (2003) Integrin beta3 Leu33Pro homozygosity and risk of cancer. J Natl Cancer Inst 95: 1150-1157, Pubmed# indexed for MEDLINE: PM:12902444
5. Chen J, Baskerville C, Han Q, Pan ZK, Huang S (2001) Alpha(v) integrin, p38 mitogen-activated protein kinase, and urokinase plasminogen activator are functionally linked in invasive breast cancer cells. J Biol Chem 276: 47901-47905, Pubmed* indexed for MEDLINE: PM:11606583
6. Chen P, Shen WZ, Karnik P (2004) Suppression of malignant growth of human breast cancer cells by ectopic expression of integrin-linked kinase. Int J Cancer 111: 881-891, Pubmed* indexed for MEDLINE: PM:15300800
7. Hintze J (2001) NCSS 2001 and PASS 2000. (Standard). USA: Number Cruncher Statistical Systems
8. Jin Q, Hemminki K, Grzybowska E, Klaes R, Soderberg M, Forsti A (2004) Re: Integrin beta3 Leu33Pro homozygosity and risk of cancer. J Natl Cancer Inst 96: 234-235, Pubmed* indexed for MEDLINE: PM:14759991
9. Johnson GL, Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912, Pubmed* indexed for MEDLINE: PM:12471242
10. Murthy MS, Reid Jr SE, Yang XF, Scanlon EP (1996) The potential role of integrin receptor subunits in the formation of local recurrence and distant metastasis by mouse breast cancer cells. J Surg Oncol 63: 77-86, Pubmed* indexed for MEDLINE: PM:8888798
11. Rolli M, Fransvea E, Pilch J, Saven A, Felding-Habermann B (2003) Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci USA 100: 9482-9487, Pubmed* indexed for MEDLINE: PM:12874388
12. Scarff RW, Torloni H (1968) Histological typing of breast tumors. In International Classification of Tumours, Sobin LH (ed) pp 13-20. Geneva: World Health Organization
13. Schnohr P, Jensen G, Lange P, Scharling H, Appleyard M (2001) The Copenhagen City Heart Study. Østerbroundersøgelsen, tables with data from the third examination 1991-1994. Eur Heart J 3: H1-H83
14. STATA SE (2004) STATA SE for Windows, rel. 8.2. (Standard). USA: StataCorp
15. Vijayan KV, Liu Y, Dong JF, Bray PF (2003) Enhanced activation of mitogen-activated protein kinase and myosin light chain kinase by the Pro33 polymorphism of integrin beta 3. J Biol Chem 278: 3860-3867, Pubmed* indexed for MEDLINE: PM:12460991
16. Wang-Gohrke S, Chang-Claude J (2004) Integrin beta3 Leu33Pro polymorphism and breast cancer risk: a population-based case-control study in Germany. Breast Cancer Res Treat 88: 231-237, Pubmed# indexed for MEDLINE: PM:15609125
17. Wewer UM, Shaw LM, Albrechtsen R, Mercurio AM (1997) The integrin alpha 6 beta 1 promotes the survival of metastatic human breast carcinoma cells in mice. Am J Pathol 151: 1191-1198, Pubmed# indexed for MEDLINE: PM:9358743
18. Zimrin AB, Gidwitz S, Lord S, Schwartz E, Bennett JS, White GC, Poncz M (1990) The genomic organization of platelet glycoprotein Ilia. J Biol Chem 265: 8590-8595, Pubmed* indexed for MEDLINE: PM:2341395